Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight
The clinical practicability of MAL-ADL-PDT was demonstrated under real-world conditions by effective lesion reduction and predominantly none-to-mild procedural pain. Thus, MAL-ADL-PDT is a convenient way for healthcare professionals to deliver PDT treatment to patients with AK located on the face and scalp.
Authors
- Rajeev Chavda (ORCID: https://orcid.org/0000-0002-1959-1563)
- Uwe Paasch (ORCID: https://orcid.org/0000-0003-3725-0284)
- Brian M. Lang (ORCID: https://orcid.org/0000-0003-1121-5982)
- Wolfgang G. Philipp‐Dormston (ORCID: https://orcid.org/0000-0002-2845-654X)
- Sara W. Quist (ORCID: https://orcid.org/0000-0003-3871-4239)
- Min-Woo Bae
- Rolf-Markus Szeimies
- Matthias Hoffmann
- Matthias Brückner
- Jörg Fränken
- Bernd Großmann
Institutions
- Witten/Herdecke University (DE)
- Koblenz University of Applied Sciences (DE)
- Johannes Gutenberg University Mainz (DE)
- Klinikum Vest (DE)
- Praxis (United States) (US)
- Knappschaftskrankenhaus Recklinghausen (DE)
- Galderma (France) (FR)
- Galderma (Switzerland) (CH)
- Praxis (EE)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1093/bjd/ljae437
- Citations
- 6
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.51